Cancer News and Research

Latest Cancer News and Research

Obesity becoming serious problem, comparable to cigarette smoking

Dr. Charles H. Hennekens, M.D., Dr.P.H., the first Sir Richard Doll Professor and senior academic advisor to the dean in the Charles E. Schmidt College of Medicine at Florida Atlantic University has published a report in the current issue of the American Journal of Medicine that obesity is becoming as big a hazard worldwide, comparable to cigarette smoking.

1 Feb 2013

Over half of countries struggling to prevent and manage cancer

More than half of all countries worldwide are struggling to prevent cancer and provide treatment and chronic care to cancer patients, warns a recent World Health Organization (WHO) survey for World Cancer Day. This means, currently many of these countries do not have a functional cancer control plan that includes prevention, early detection, treatment and care. There is an urgent need to help countries to reduce cancer deaths and provide appropriate long-term treatment and care to avoid human suffering and protect countries’ social and economic development.

1 Feb 2013

Innate lymphoid cells may be new therapeutic target in treating atopic dermatitis

The increasing incidence of allergic skin diseases, and the accompanying economic burden and heightened risk of developing other allergic conditions, have spurred researchers to look for better ways to control these immune system-based disorders.

1 Feb 2013

Endothelial cells can trigger changes in cancer cells without direct contact

Blood vessels that supply oxygen and nutrients to tumors can also deliver something else - a signal that strengthens nearby cancer cells, making them more resistant to chemotherapy, more likely to spread to other organs and more lethal, scientists at The University of Texas MD Anderson Cancer Center report online in Cancer Cell.

1 Feb 2013

Weill Cornell and NewYork-Presbyterian create pioneering Institute for Precision Medicine

Recognizing that medicine is not "one size fits all," Weill Cornell Medical College and NewYork-Presbyterian Hospital have created the pioneering Institute for Precision Medicine at Weill Cornell and NewYork-Presbyterian/Weill Cornell Medical Center. This new, cutting-edge translational medicine research hub will explore the new frontier of precision medicine, offering optimal targeted, individualized treatment based on each patient's genetic profile.

1 Feb 2013

Notch protein responsible for activating GATA2 gene to generate hematopoietic stem cells

Researchers from the group on stem cells and cancer at IMIM (Hospital del Mar Medical Research Institute) have deciphered one of the gene regulation circuits which would make it possible to generate hematopoietic blood cells, i.e. blood tissue stem cells.

1 Feb 2013

Moderate gum disease causes severe infection and inflammation in AIDS animal model

Texas Biomed scientists in San Antonio have found that moderate gum disease in an animal model exposed to an AIDS- like virus had more viral variants causing infection and greater inflammation. Both of these features have potential negative implications in long term disease progression, including other kinds of infections, the researchers say in a new report.

1 Feb 2013

NIH stresses importance of genomics in nursing care in medical literature

On April 14, 2003 a map of the human genome was completed, ushering in a new era of genetics in medicine with applications that include genetic testing; newborn screening; susceptibility to diseases such as cancer, cardiovascular disease, or psychiatric conditions; screening, diagnosis and monitoring of disease; and treatment planning.

1 Feb 2013

Merck full-year 2012 worldwide sales decrease 2% to $47.3 billion

Merck, known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of 2012.

1 Feb 2013

Bioelectric signals can identify cells that are likely to develop into tumors

Biologists at Tufts University School of Arts and Sciences have discovered a bioelectric signal that can identify cells that are likely to develop into tumors. The researchers also found that they could lower the incidence of cancerous cells by manipulating the electrical charge across cells' membranes.

1 Feb 2013

Three Robert Wood Johnson members win Edward J. Ill Excellence in Medicine Awards

Three members of the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School faculty have been named 2013 recipients of the prestigious Edward J. Ill Excellence in Medicine Awards, highlighting their expertise as exceptional educators or researchers.

1 Feb 2013

Study demonstrates new fragile genomic sites responsible for chromosomal alterations in tumors

Cancer arises from the accumulation of mutations and structural changes in chromosomes, which in some cases give rise to combinations that favour the growth or expansion of the disease. In this context, chromosomes tend to lose or duplicate entire regions, although, the mechanisms that initiate these chromosomal abnormalities are not fully understood.

1 Feb 2013

Galectin submits GR-MD-02 IND application with FDA for treatment of liver fibrosis

Galectin Therapeutics, the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced today that it submitted an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) on January 30, 2013.

1 Feb 2013

University of Leicester's GENIE to host Lifestyle and Cancer Awareness Workshop on Feb. 23

Women with a family history of breast or ovarian cancer are invited to meet with experts who will advise on preventing or delaying the disease. The University of Leicester's Genetics Education Networking for Innovation and Excellence (GENIE) will hold its third Lifestyle and Cancer Awareness Workshop on Saturday, February 23.

1 Feb 2013

Mental health in young people: an interview with Professor Colum Dunne

Ireland, and many other countries, is witnessing increases in problematic and complex youth mental health challenges. In Ireland, specifically, there has been a rash of high profile cases where young people have unfortunately not been able to deal with stress, bullying and other issues.

1 Feb 2013

ArQule, Daiichi Sankyo initiate enrollment in tivantinib Phase 3 trial for hepatocellular carcinoma

Daiichi Sankyo Company, Limited and ArQule, Inc. today announced that the first patient has been enrolled in the pivotal Phase 3 METIV-HCC (MET-high patients with tivantinib in HCC) trial of tivantinib (ARQ 197).

31 Jan 2013

Major East Coast academic medical center acquires BSD-500 Hyperthermia System

BSD Medical Corporation announced today that a major East Coast academic medical center has purchased a BSD-500 Hyperthermia System (BSD-500).

31 Jan 2013

Celsion's ThermoDox does not meet primary endpoint in Phase III HCC study

Celsion Corporation, a leading oncology drug development company, today announced that ThermoDox in combination with radiofrequency ablation (RFA) did not meet the primary endpoint of the Phase III HEAT Study in patients with hepatocellular carcinoma (HCC), also known as primary liver cancer.

31 Jan 2013

FDA approves Biotest's BIVIGAM to treat Primary Humoral Immunodeficiency

Biotest Pharmaceuticals Corporation (BPC), a wholly owned U.S. subsidiary of Biotest AG, recently announced the U.S. Food and Drug Administration's (FDA) approval of BIVIGAM, its new intravenous immune globulin, for the treatment of patients with Primary Humoral Immunodeficiency (PI).

31 Jan 2013

DelMar announces second closing of $1.5M in private placement

DelMar Pharmaceuticals, Inc. today announced the second closing in a private placement consisting of approximately 1.9 million units of its securities to qualified accredited investors, for gross proceeds of approximately $1.5 million. The total amount raised in the private placement is $6.9 million.

31 Jan 2013

Cancer News and Research

Latest Cancer News and Research

Obesity becoming serious problem, comparable to cigarette smoking

Over half of countries struggling to prevent and manage cancer

Innate lymphoid cells may be new therapeutic target in treating atopic dermatitis

Endothelial cells can trigger changes in cancer cells without direct contact

Weill Cornell and NewYork-Presbyterian create pioneering Institute for Precision Medicine

Notch protein responsible for activating GATA2 gene to generate hematopoietic stem cells

Moderate gum disease causes severe infection and inflammation in AIDS animal model

NIH stresses importance of genomics in nursing care in medical literature

Merck full-year 2012 worldwide sales decrease 2% to $47.3 billion

Bioelectric signals can identify cells that are likely to develop into tumors

Three Robert Wood Johnson members win Edward J. Ill Excellence in Medicine Awards

Study demonstrates new fragile genomic sites responsible for chromosomal alterations in tumors

Galectin submits GR-MD-02 IND application with FDA for treatment of liver fibrosis

University of Leicester's GENIE to host Lifestyle and Cancer Awareness Workshop on Feb. 23

Mental health in young people: an interview with Professor Colum Dunne

ArQule, Daiichi Sankyo initiate enrollment in tivantinib Phase 3 trial for hepatocellular carcinoma

Major East Coast academic medical center acquires BSD-500 Hyperthermia System

Celsion's ThermoDox does not meet primary endpoint in Phase III HCC study

FDA approves Biotest's BIVIGAM to treat Primary Humoral Immunodeficiency

DelMar announces second closing of $1.5M in private placement

Industry Focus eBook - Immunology (3rd edition) eBook

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Immunology (3rd edition) eBook

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Newsletters you may be interested in